Addressing Racial and Ethnic Disparities in Cancer Care Delivery (Monday, April 20, 2009 -- 1:00 to 2:00 PM MDT)

Yong Cui (Meharry Medical College): “Breast cancer risk factors among Caucasian-American and African-American women”

Upender Manne (University of Alabama at Birmingham): “MicroRNA profiles of colorectal adenocarcinomas - racial disparity”

Deborah Wujcik (Vanderbilt University): “Enhancement of recruitment of African-Americans to national oncology clinical trials”

Jean Ford (Johns Hopkins Bloomberg School of Public Health): “Determinants of screening colonoscopy among African American older adults”

Late-Breaking Science and Clinical Trials press conference (Sunday, April 19, 2009 -- 3:00 to 4:00 PM MDT) is still in final development … more details to follow.

Accelerating Bench to Bedside - Getting Better Treatments to Cancer Patients (Sunday, April 19, 2009 -- 1:00 to 2:00 PM MDT)

Florence Hofman (USC Keck School of Medicine): “2,5-Dimethyl-celecoxib exerts antiangiogenic effects on the tumor vasculature”

Richard Paul Junghans (Boston University School of Medicine): “Phase I trial of anti-PSMA designer T cells in prostate cancer”

Lori Friedman (Genentech): “Preclinical analysis of combined PI3K and MEK inhibition as a strategy for the treatment of cancer”

Anthony Williams (USC/Norris Comprehensive Cancer Center): “Development of a membrane microfilter device for capture and characterization of circulating tumor cells in blood”

Mamta Gupta (Mayo Clinic): “Combined inhibition of histone deacetylase and mTOR: A novel therapeutic approach for pancreatic cancer”

Appraising Cancer Prevention - Diet, Lifestyle and Beyond (Monday, April 20, 2009 -- 7:45 to 8:45 AM MDT)

Karen Sie (University of Toronto): “The effect of in utero and post natal folic acid supplementation on genomic DNA methylation in the offspring”

Andrea Burnett-Hartman (Fred Hutchinson Cancer Research Center): “Colorectal polyp type and the association with smoking, charred meat intake, and mEH”

Cornelia Ulrich (Fred Hutchinson Cancer Research Center): “COX1 and COX2 polymorphisms, NSAID use, and colorectal cancer risk in the Colon Cancer Family Registry”

Jianfeng Xu (Wake Forest University School of Medicine): “Estimation of absolute risk for prostate cancer using SNPs and family history”

Neil Caporaso (NCI-DCEG): “Evidence of immune disruption up to 9.8 years prior to diagnosis of chronic lymphocytic leukemia: a prospective study”

Putting Knowledge to Work - The Genetics of Cancer (Tuesday, April 21, 2009 -- 10:00 to 11:00 AM MDT)

Charles Mullighan (St. Jude Children's Research Hospital): “Frequent JAK mutations in pediatric acute lymphoblastic leukemia (ALL) with poor outcome: A new therapeutic target in resistant disease”

Xifeng Wu (University of Texas, M.D. Anderson Cancer Center): “Genetic variants in microRNA processing pathway genes and ovarian cancer risk”

Susan Slager (Mayo Clinic): “Confirmation of a set of genetic susceptibility variants for chronic lymphocytic leukemia (CLL)”

Sunita Setlur (Brigham and Women's Hospital): “Association of UGT2B17, UGT2B7 and UGT2B28 gene copy number with prostate cancer risk”

Gangning Liang (USC/Norris Comprehensive Cancer Center): “DNA methylation profiling reveals a field defect in bladders with cancer and a distinct hypomethylated pattern in non-invasive bladder tumors”

Glenn Silver

Vice President

Chamberlain

Healthcare Public Relations

an inVentiv health company

111 Broadway, 19th Floor New York, NY 10006
T 212-884-0646 F 212-884-0628 C 201-486-0952 gsilver@chamberlainpr.com